Skip to content
10-Q

Quarterly Report

ACTAVIA LIFE SCIENCES, INC.

0001213900-23-016696

← back to feed
Filed
Mar 2, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · Mar 2, 2023 771.81M sh
Current Liabilities Q1 2023 · Dec 31, 2022 $1.77M
Current Liabilities Q1 2023 · Sep 30, 2022 $1.68M
Total Liabilities Q1 2023 · Dec 31, 2022 $1.87M
Total Liabilities Q1 2023 · Sep 30, 2022 $1.77M
Total Assets Q1 2023 · Dec 31, 2022 $60.58K
Total Assets Q1 2023 · Sep 30, 2022 $85.28K
Shares Diluted Q1 2023 · Dec 31, 2021 68.91M sh
Operating Cash Flow Q1 2023 · Dec 31, 2021 −$74.78K
Stockholders Equity Q1 2023 · Dec 31, 2021 −$2.5M
Stockholders Equity Q1 2023 · Sep 30, 2021 −$2.75M
Eps Diluted Q1 2023 · Dec 31, 2021 $0.00
Eps Basic Q1 2023 · Dec 31, 2021 $0.00
Sga Expense Q1 2023 · Dec 31, 2021 $72.66K
Rd Expense Q1 2023 · Dec 31, 2021 $9.14K
Net Income Q1 2023 · Dec 31, 2021 −$274.63K
Operating Income Q1 2023 · Dec 31, 2021 −$81.79K